ORMP
Oramed Pharmaceuticals Inc
4.80$
+1.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +20.9% | +62.5% | -9.6% | +22.4% | -26.9% | +28.8% | +186.8% | +26.3% | +36.4% | -29.6% | +48.7% | |
| – | -20.2% | +79.8% | -35.0% | +52.9% | +7.4% | +21.6% | +135.3% | +64.8% | +3.5% | -11.9% | -6.9% | |
| – | +82.3% | +21.6% | +1.6% | +25.9% | -33.4% | +479.6% | +300.3% | -47.6% | -77.6% | +501.0% | -15.6% | |
| – | -19.1% | +80.0% | -35.1% | +51.4% | +6.0% | +23.6% | +135.9% | +65.4% | +4.1% | -12.4% | -11.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +51.2% | +990.4% | +17.0% | -16.4% | -6.2% | -23.0% | -2.3% | -8.7% | +449.9% | -82.8% | +213.4% | |
| – | +53.0% | +143.2% | +42.6% | -11.8% | +16.6% | -14.5% | +47.2% | -14.0% | +826.1% | -89.3% | +235.7% | |
| – | – | – | – | – | – | – | +195.5% | +90.0% | +20,661.1% | -99.6% | +31.9% | |
| – | +2.9% | +48.1% | -59.5% | +98.8% | +17.8% | -55.6% | +338.7% | -16.5% | -74.7% | +43.2% | -43.9% | |
| – | +19.4% | +5.5% | -26.5% | +61.7% | -37.7% | +69.5% | +252.1% | +31.1% | +7.9% | -10.7% | +36.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.1% | +16.7% | +5.4% | +11.8% | +17.3% | +17.6% | +38.7% | +37.0% | +4.0% | +0.7% | +3.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.